Autologous followed by allogeneic versus tandem-autologous transplantation in high-risk, newly diagnosed multiple myeloma: a systematic review and meta-analysis
CONCLUSION: Auto-allo-SCT seemed to be associated with improvements in PFS and CR when compared to tandem-auto-SCT in patients with HRMM, but it did not lead to a significant improvement in OS. Furthermore, patients in the auto-allo-SCT group were at a higher risk of developing TRM and NRM. Auto-allo-SCT transplantation should not be routinely incorporated into HRMM therapy but rather should be considered investigational.PMID:37850613 | DOI:10.1080/16078454.2023.2269509
Source: Hematology - Category: Hematology Authors: Min Wei Chunhong Xie Jinxiong Huang Qin Liu Yongrong Lai Source Type: research
More News: Databases & Libraries | Hematology | Myeloma | Stem Cell Therapy | Stem Cells | Study | Transplants